AU2002358815A1 - Methods of diagnosing and treating diabetes and obesity - Google Patents
Methods of diagnosing and treating diabetes and obesityInfo
- Publication number
- AU2002358815A1 AU2002358815A1 AU2002358815A AU2002358815A AU2002358815A1 AU 2002358815 A1 AU2002358815 A1 AU 2002358815A1 AU 2002358815 A AU2002358815 A AU 2002358815A AU 2002358815 A AU2002358815 A AU 2002358815A AU 2002358815 A1 AU2002358815 A1 AU 2002358815A1
- Authority
- AU
- Australia
- Prior art keywords
- obesity
- diagnosing
- methods
- treating diabetes
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/ES2002/000566 WO2004048610A1 (en) | 2002-11-28 | 2002-11-28 | Methods of diagnosing and treating diabetes and obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002358815A1 true AU2002358815A1 (en) | 2004-06-18 |
Family
ID=32338282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002358815A Abandoned AU2002358815A1 (en) | 2002-11-28 | 2002-11-28 | Methods of diagnosing and treating diabetes and obesity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002358815A1 (en) |
| WO (1) | WO2004048610A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3199299A (en) * | 1998-03-23 | 1999-10-18 | Musc Foundation For Research Development | Methods for identifying a risk to ucp2 and ucp3 gene variant-related afflictionsand compositions thereof |
| GB0000992D0 (en) * | 2000-01-18 | 2000-03-08 | Astrazeneca Uk Ltd | Methods |
| US6608038B2 (en) * | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
| GB0024510D0 (en) * | 2000-10-06 | 2000-11-22 | Astrazeneca Ab | Methods |
| US20020177151A1 (en) * | 2001-02-26 | 2002-11-28 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of metabolic disorders, including obesity and diabetes |
-
2002
- 2002-11-28 WO PCT/ES2002/000566 patent/WO2004048610A1/en not_active Ceased
- 2002-11-28 AU AU2002358815A patent/AU2002358815A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004048610A1 (en) | 2004-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002322394A1 (en) | Method for treating diabetes and obesity | |
| AU2003219934A1 (en) | Method of treatment or prevention of obesity | |
| AU2003207717B9 (en) | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia | |
| IL218909A0 (en) | Treatment of diabetes | |
| AU2003287436A1 (en) | Apparatus and methods for treatment of morbid obesity | |
| AU2003243420A1 (en) | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia | |
| AU2003259925A1 (en) | Well treatment apparatus and method | |
| AU2003220194A1 (en) | Heart valve fixation process and apparatus | |
| AU2003251191A1 (en) | Microorganisms for inhibiting obesity and diabetes mellitus | |
| AU2003257702A1 (en) | Optometric device and optometric method | |
| AU2002258428A1 (en) | Methods for the treatment of metabolic disorders, including obesity and diabetes | |
| AU2003297460A1 (en) | TREATMENT OF OBESITY AND ASSOCIATED CONDITIONS WITH TGF-Beta INHIBITORS | |
| AU2003277259A1 (en) | Immunoassay and method of use | |
| IL165304A0 (en) | Method of treating diabetes | |
| AU2003268032A1 (en) | Composition and methods for treatment and screening | |
| AU2002312211A1 (en) | Methods and reagents for diagnosis and treatment of insulin resistance and related conditions | |
| AU6050000A (en) | Improved method of treating type ii diabetes and obesity | |
| WO2003102163A8 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| AU2003243427A1 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| EP1572085A3 (en) | Methods and compositions for treating and diagnosing diabetes | |
| EP1572085A4 (en) | Methods and compositions for treating and diagnosing diabetes | |
| EP1511850A4 (en) | Methods of treating and diagnosing diabetes with cx3cr1 modulators | |
| AU2003237483A1 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| AU2003231279A1 (en) | Prevention and treatment of type 2 diabetes | |
| AU2003240556A1 (en) | Methods of diagnosing and treating diabetes and insulin resistance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |